NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 294 filers reported holding NEKTAR THERAPEUTICS in Q3 2019. The put-call ratio across all filers is 0.81 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $376,000 | +0.5% | 10,572 | -5.0% | 0.00% | 0.0% |
| Q1 2019 | $374,000 | -47.1% | 11,128 | -48.3% | 0.00% | -40.0% |
| Q4 2018 | $707,000 | -46.3% | 21,511 | -0.4% | 0.01% | -44.4% |
| Q3 2018 | $1,317,000 | +490.6% | 21,602 | +931.6% | 0.01% | +350.0% |
| Q1 2018 | $223,000 | -94.0% | 2,094 | -98.6% | 0.00% | -92.3% |
| Q3 2017 | $3,695,000 | +35.0% | 153,958 | +9.9% | 0.03% | +36.8% |
| Q2 2017 | $2,738,000 | – | 140,043 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rhenman & Partners Asset Management AB | 1,350,000 | $22,950,000 | 1.87% |
| MAVERICK CAPITAL LTD | 6,655,625 | $113,146,000 | 1.81% |
| Camber Capital Management LP | 2,500,000 | $42,500,000 | 1.49% |
| Bellevue Group AG | 3,866,258 | $65,726,000 | 0.75% |
| Adero Partners, LLC | 51,500 | $876,000 | 0.75% |
| Goodman Financial Corp | 108,342 | $1,842,000 | 0.64% |
| CM Management, LLC | 35,000 | $595,000 | 0.55% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 424,504 | $7,217,000 | 0.43% |
| RICE HALL JAMES & ASSOCIATES, LLC | 568,379 | $9,662,000 | 0.34% |
| Burleson & Company, LLC | 107,736 | $1,832,000 | 0.32% |